Kerr S, Bedston S, Bradley DT, Joy M, Lowthian E, Mulholland RM et al.
Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales.
International Journal of Epidemiology.

Agrawal A, Bedston S, McCowan C, Oke J, Patterson L, Robertson C et al.
Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales.
Nature Communications.

Simpson CR, Kerr S, Katikireddi S.V, McGowan C, et.al,
Second-dose Oxford-AstraZeneca and Pfizer-BioNTech vaccines and blood clotting and bleeding events in Scotland.
Nature Communications.

PHOSP-COVID Collaborative Group,
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study.
The Lancet Respiratory Medicine.

Kerr S, Joy M, Torabi F, Bedston S, Akbari A, Agrawal U et al,
First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 12 million individuals in England, Scotland and Wales.
PLOS medicine.

Agrawal U, Katikireddi SV, McCowan C, Mulholland RH, Azcoaga-Lorenzo A, Amele S, Fagbamigbe et al
COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study .
The Lancet Respiratory Medicine.

Sheikh A, Kerr S, Woolhouse M, McMenamin J, Robertson C,
Severity of Omicron variant of concern and vaccine effectiveness against symptomatic disease: national cohort with nested test negative design study in Scotland - preprint , publication - Lancet Infectious Diseases.

Ting S, P Jiafeng, Katikireddi V, McCowan C, Kerr S, Agrawal U et al,
Risk of COVID-19 hospital admission among children aged 5–17 years with asthma in Scotland: a national incident cohort study.
The Lancet Respiratory Medicine.

Simpson CR, Kerr S, Shi T, Vasileiou E, Moore E, McCowan C et al,
External validation of the QCovid risk prediction algorithm for risk of COVID-19 hospitalisation and mortality in adults: national validation cohort study in Scotland.

Simpson CR, Shi T, Vasileiou E, Katikireddi SV, Kerr S, Moore E et al,
First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland.
Nature Medicine.

PHOSP-COVID Collaborative Group,
Physical, cognitive and mental health impacts of COVID-19 following hospitalisation -- a multi-centre prospective cohort study.
The Lancet Respiratory Medicine.

Vasileiou E, Simpson CR, Robertson C, Shi T, Kerr S, et al,
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study.
The Lancet.